Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1592, Issue 3, 2002, Pages 265-280

  Martin, Michael U ^a   Wesche, Holger ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b AMGEN INC   (United States)

Author keywords

Innate immunity; Interleukin 1 receptor associated kinase; Interleukin 1 receptor signaling; Interleukin 18 receptor signaling; Toll like receptor signaling

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; LEUCINE; MEMBRANE PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHOTRANSFERASE; PROTEIN; PROTEIN TOLLIP; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADAPTATION; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, DIFFERENTIATION; CARRIER PROTEINS; DROSOPHILA PROTEINS; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-18; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE GLYCOPROTEINS; MODELS, MOLECULAR; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN KINASES; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-18; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 0037064536     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(02)00320-8     Document Type: Review

References (175)

1. O'Neill L.A.J., Dinarello C.A. The IL-1 receptor/Toll-like superfamily: crucial receptors for inflammation and host defense. Immunol. Today. 21:2000;206-209.
2. O'Neill L. The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence. Biochem. Soc. Trans. 28:2000;557-562.
3. Fallon P.G., Allen R.L., Rich T. Primitive Toll signalling: bugs, flies, worms and man. Trends Immunol. 22:2001;63-66.
4. Sims J.E., March C.J., Cosman D., Widmer M.B., MacDonald H.R., McMahan C.J., Grubin C.E., Wignall J.M., Jackson J.L., Call S.M., Friend D., Alpert A.R., Gillis S., Urdal D.L., Dower S.K. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science. 241:1988;585-589.
5. Greenfeder S.A., Nunes P., Kwee L., Labow M., Chizzonite R.A., Ju G. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 270:1995;13757-13765.
6. Parnet P., Garka K.E., Bonnert T.P., Dower S.K., Sims J.E. IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologue T1/ST2 and IL-1R AcP. J. Biol. Chem. 271:1996;3967-3970.
7. Torigoe K., Ushio S., Okura T., Kobayashi S., Taniai M., Kunikata T., Murakami T., Sanou O., Kojima K., Fujii M., Ohta T., Ikeda M., Ikegami H., Kurimoto M. Purification and characterization of the human interleukin-18 receptor. J. Biol. Chem. 272:1997;25737-25742.
8. Born T.L., Thomassen E., Bird T.A., Sims J.E. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J. Biol. Chem. 273:1998;29445-29450.
9. Born T.L., Smith D.E., Garka K.E., Renshaw B.R., Bertles J.S., Sims J.E. Identification and characterization of two members of a novel class of interleukin-1 receptor (IL-1R) family. J. Biol. Chem. 275:2000;29946-29954.
10. Thomassen E., Renshaw B.R., Sims J.E. Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily. Cytokine. 11:1999;389-399.
11. Kumar S., McDonell P.C., Lehr R., Tierney L., Tzimas M.N., Griswold D.E., Capper E.A., Tal-Singer R., Wells G.I., Doyle M.L., Young P.R. Identification and initial characterization of four novel members of the interleukin-1 family. J. Biol. Chem. 276:2000;10308-10314.
12. Smith D.E., Renshaw B.R., Ketchem R.B., Kubin M., Garka K.E., Sims J.E. Four new members expand the interleukin-1 superfamily. J. Biol. Chem. 275:2000;1169-1175.
13. Dunn E., Sims J.E., Nicklin M.J., O'Neill L.A. Annotating genes with potential roles in the immune system: six new members of the IL-1 family. Trends Immunol. 22:2001;533-536.
14. Debets R., Timans J.C., Homey B., Zurawski S., Sana T.R., Lo S., Wagner J., Edwards G., Clifford T., Menon S., Bazan F.F., Kastelein R.A. Two novel IL-1 family members, IL-1delta and IL-1epsilon, function as an antagonist and agonist of NFkappaB activation through the orphan receptor-related protein 2. J. Immunol. 167:2001;1440-1446.
15. McMahan C.J., Slack J.L., Mosley B., Cosman D., Lupton S.D., Brunton L.L., Grubin C.E., Wignall J.M., Jenkins N.A., Brannan C.I., Copeland N.G., Huebner K., Croce C.M., Cannizzarro L.A., Benjamin D., Dower S.K., Spriggs M.K., Sims J.E. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10:1991;2821-2832.
16. Colotta F., Dower S.K., Sims J.E., Mantovani A. The type II 'decoy' receptor: a novel regulatory pathway for interleukin-1. Immunol. Today. 15:1994;562-566.
17. Lang D., Knop J., Wesche H., Raffetseder U., Kurrle R., Boraschi D., Martin M.U. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J. Immunol. 161:1998;6871-6877.
18. Mantovani A., Locati M., Vecchi A., Sozzani S., Allavena P. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol. 22:2001;328-336.
19. Akira A., Takeda K., Kasiho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:2001;675-680.
20. Hallmann M., Rämet M., Ezekowitz R.A. Toll-like receptors as sensors of pathogens. Pediatr. Res. 50:2001;315-321.
21. Loh Y.-T., Martin G.B. The Pto bacterial resistance gene and the Fen insecticide sensitivity gene encode functional protein kinases with serine/threonine specificity. Plant Physiol. 108:1995;1735-1739.
22. Morisato D., Anderson K.V. The spätzle gene encodes a component of the extracellular signaling pathway establishing the dorsal-ventral pattern of the Drosophila embryo. Cell. 76:1994;677-688.
23. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., Hoffmann J.A. The dorsoventral regulatory gene cassette spätzle/toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 86:1996;973-983.
24. Eldon E., Kooyer S., D'Evelyn A., Duman M., Lawinger P., Botas J., Bellen H. The Drosophila 18 wheeler is required for morphogenesis and has striking similarities to Toll. Development. 120:1994;885-899.
25. Tauszig-Delamasure S., Bilak H., Capovilla M., Hoffmann J.A., Imler J.L. Drosophila MyD88 is required for the response to fungal and Gram-positive bacterial infection. Nat. Immunol. 3:2002;91-97.
26. Tauszig S., Jouanguy E., Hoffmann J.A., Imler J.-L. Toll-related receptors and the control of antimicrobial peptide expression in Drosophila. Proc. Natl. Acad. Sci. U. S. A. 97:2000;10520-10525.
27. Medzhitov R., Johnson-Hurlburt P., Janeway C.A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:1997;394-397.
28. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature. 406:2000;782-787.
29. Brown P. Cinderella goes to the ball. News feature. Nature. 410:2001;1018-1020.
30. Polotorak A., Smrinova I., He X., Liu M.-Y., Van Huffel C., Birdwell D., Alejos E., Silva M., Du X., Thompson P., Chan E.K.I., Ledesma J., Roe B., Clifton S., Vogel S.N., Beutler B. Genetic and physical mapping of the LPS locus: identification of the Toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol. Diseases. 24:1998;340-355.
31. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejoy E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in the Tlr4 gene. Science. 282:1998;2085-2088.
32. Kirschning C., Wesche H., Ayres T.M., Rothe M. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med. 188:1998;2091-2097.
33. Qureshi S.T., Larivière L., Leveque G., Clermont S., Moore K.J., Gros P., Malo D. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189:1999;615-625.
34. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:1999;3749-3752.
35. Lien E., Sellati T.J., Yoshimura A., Flo T.H., Rawadi G., Finberg R.W., Carroll J.D., Espevik T., Ingalls R.R., Radolf J.D., Golenbock D.T. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274:1999;33419-33425.
36. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., Takeda K., Akira S. Differential roles for TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity. 11:1999;443-451.
37. Sasu S., LaVerda D., Qureshi N., Golenbock D.T., Beasley D. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via Toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ. Res. 89:2001;244-250.
38. Vabulas R.M., Ahmad-Nejad P., da Costa C., Miethke T., Kirschning C.J., Häcker H., Wagner H. Endocytosed hsp60s use Toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-1 receptor signaling pathway in innate immune cells. J. Biol. Chem. 276:2001;31332-31339.
39. Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C., Goodlett D.R., Eng J.K., Akira S., Underhill D.M., Aderem A. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 410:2001;1099-1103.
40. Gewirtz A.T., Navas T.A., Lyons S., Godwoski P.J., Madara J.L. Bacterial flagellin activates basolaterally expressed tlr5 to induce epithelial proinflammatory gene expression. J. Immunol. 167:2001;1882-1885.
41. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 413:2001;732-738.
42. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo H., Hoshino K., Horiuchi T., Tomizawa H., Takeda K., Akira S. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3:2002;196-200.
43. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. A Toll-like receptor recognizes bacterial DNA. Nature. 408:2000;740-745.
44. Ohashi K., Burkart V., Flohé S., Kolb H. Heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex. J. Immunol. 164:2000;558-561.
45. Smiley S.T., King J.A., Hancock W.W. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J. Immunol. 167:2001;2887-2894.
46. Matzinger P. The danger model in its historical context. Scand. J. Immunol. 54:2001;4-9.
47. Shimazu R., Akashi A., Ogata H., Nagai Y., Fukudome K., Miyake K., Kimoto M. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:1999;1777-1782.
48. Ulevitch R.J., Tobias P.S. Recognition of Gram-negative bacteria and endotoxin by the innate immune system. Curr. Opin. Immunol. 11:1999;19-22.
49. Beutler B., Poltorak A. Positional cloning of Lps, and the general role of toll-like receptors in the innate immune response. Eur. Cytokine Netw. 11:2000;143-152.
50. Chuang T., Ulevitch R.J. Identification of hTLR10: an novel human Toll-like receptor preferentially expressed in immune cells. Biochim. Biophys. Acta. 1518:2001;157-161.
51. Rock F.L., Hardiman G., Timans J.C., Kastelein R.A., Bazan J.F. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. U. S. A. 95:1998;588-593.
52. Muzio M., Bosisio D., Polentarutti N., D'Amico G., Stoppacciao A., Mancinelli R., van't Veer C., Penton-Rol G., Ruco L.P., Allavena P., Mantovani A. Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol. 164:2000;5998-6004.
53. Muzio M., Polentarutti N., Bosisio D., Prahladan M.K., Mantovani A. Toll-like receptors: a growing family of immune receptors that are differentially expressed and regulated by different leukocytes. J. Leukoc. Biol. 67:2000;450-456.
54. Zarember K.A., Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168:2002;554-561.
55. Tamai R., Sakuta T., Matsushita K., Torii M., Takeuchi O., Akira S., Akashi S., Espevik T., Sugawara S., Takeda H. Human gingival CD14(+) fibroblasts primed with gamma interferon increase production of interleukin-8 in response to lipopolysaccharide through up-regulation of membrane CD14 and MyD88 mRNA expression. Infect. Immun. 70:2002;1272-1278.
56. Abreu M.T., Arnold E.T., Thomas L.S., Gonsky R., Zhou Y., Hu B., Arditi M. TLR4 and MD-2 expression are regulated by immune-mediated signals in human intestinal epithelial cells. J. Biol. Chem. 277:2002;20431-20437.
57. Bosisio D., Polentarutti N., Sironi M., Bernasconi S., Miyake K., Webb G.R., Martin M.U., Mantovani A., Muzio M. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-γ: a molecule basis for priming and synergism with bacterial lipopolysaccharide. Blood. 99:2002;3427-3431.
58. Fitzgerald K.A., Palsson-McDermott E.M., Bowie A.G., Jefferies C.A., Mansell A.S., Brady G., Brint E., Dunne A., Gray P., Harte M.T., McMurray D., Smith D.E., Sims J.E., Bird T.A., O'Neill L.A.J. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 413:2001;78-83.
59. Horng T., Barton G.M., Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2:2001;835-841.
60. Hultmark D. Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family. Biochem. Biophys. Res. Commun. 199:1994;144-146.
61. Hardiman G., Jenkins N.A., Copeland N.G., Gilbert D.J., Garcia D.K., Naylor S.L., Kastelein R.A., Bazan J.F. Genetic structure and chromosomal mapping of MyD88. Genomics. 45:1997;332-339.
62. Bonnert T.P., Garka K.E., Parnet P., Sonoda G., Testa J.R., Sims J.E. The cloning and characterization of human MyD88: a member of an IL-1 receptor related family. FEBS Lett. 402:1997;81-84.
63. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., Nakanishi K., Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 9:1998;143-150.
64. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:1999;115-122.
65. Sims J., Dower S.K. Interleukin-1 receptors. Eur. Cytokine Netw. 5:1994;539-546.
66. Schreuder H., Tardif C., Trump-Kallmeyer S., Soffientini A., Sarubbi E., Akeson A., Bowlin T., Yanofsky S., Barrett R.W. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature. 386:1997;194-199.
67. Vigers G.P.A., Anderson L.J., Xaffes P., Brandhuber B.J. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1β Nature. 386:1997;190-194.
68. Casadio R., Frigimelica E., Bossu P., Neumann D., Martin M.U., Tagliabue A., Boraschi D. Model of interaction of the IL-1 receptor accessory protein IL-1RAcP with the IL-1beta/IL-1R(I) complex. FEBS Lett. 499:2001;65-68.
69. Wesche H., Korherr C., Kracht M., Falk W., Resch K., Martin M.U. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1 induced activation of interleukin-1 receptor associated protein kinase (IRAK) and stress activated protein kinases (SAP-kinases). J. Biol. Chem. 277:1997;7727-7731.
70. Korherr C., Hofmeister R., Wesche H., Falk W. A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur. J. Immunol. 27:1997;262-267.
71. Huang J., Gao X., Li S., Cao Z. Recruitment of IRAK of the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc. Natl. Acad. Sci. U. S. A. 94:1997;12829-12832.
72. Cullinan E.B., Kwee L., Nunes P., Shuster D.J., Ju G., McIntyre K.W., Chizzonite R.A., Labow M.A. IL-1 receptor accessory protein is an essential component of the IL-1 receptor. J. Immunol. 161:1998;5614-5620.
73. Thomassen E., Bird T.A., Renshaw B.R., Kennedy M.K., Sims J.E. Binding of interleukin-18 to the interleukin-1 receptor homologous receptor IL-1Rrp1 leads to activation of signaling pathways similar to those used by interleukin-1. J. Interferon Cytokine Res. 18:1998;1077-1088.
74. Novick D., Kim S.H., Fantuzzi G., Reznikov L.L., Dinarello C.A., Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity. 10:1999;127-136.
75. Dinarello C.A. Targeting interleukin 18 with interleukin 18 binding protein. Ann. Rheum. Dis. 59(Suppl. 1):2000;i17-i20.
76. Guo C., Dower S.K., Holowka D., Baird B. Fluorescence resonance energy transfer reveals interleukin (IL)-1-dependent aggregation of IL-1 type I receptors that correlates with receptor activation. J. Biol. Chem. 270:1995;27562-27568.
77. Hajjar A.M., O'Mahony D.S., Ozinsky A., Underhill D.M., Anderson A., Klebanoff S.J., Wilson C.B. Functional interactions between Toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J. Immunol. 166:2001;15-16.
78. Wyllie D.H., Kiss-Toth E., Visitin A., Smith S.C., Boussouf S., Segal D.M., Duff G.W., Dower S.K. Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses. J. Immunol. 165:2000;7125-7132.
79. Bulut Y., Faure E., Thomas L., Equilis O., Arditi M. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J. Immunol. 167:2001;987-994.
80. Yang R.-B., Mark M.R., Gurney A.L., Godowski P.J. Signaling events induced by lipopolysaccharide-activated Toll-like receptor 2. J. Immunol. 163:1999;639-643.
81. Muta T., Takeshige K. Essential roles of CD14 and lipopolysaccharide-binding protein for activation of toll-like receptor (TLR)2 as well as TLR4 reconstitution of TLR2- and TLR4-activation by distinguishable ligands in LPS preparations. Eur. J. Biochem. 268:2001;4580-4589.
82. da Silva Correia J., Soldau K., Christen U., Tobias P.S., Ulevitch R.J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex: transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 276:2001;21129-21135.
83. Yang H., Young D.W., Gusovsky F., Chow J.C. Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1. J. Biol. Chem. 275:2000;20861-20866.
84. Viriyakosol S., Tobias P.S.D., Kitchens R.L., Kirkland T.N. MD-2 binds to bacterial lipopolysaccharide. J. Biol. Chem. 276:2001;38044-38051.
85. Miura Y., Shimazu R., Myake K., Akashi A., Ogata H., Yamashita Y., Narisawa Y., Kimoto M. RP105 is associated with MD-1 and transmits an activation signal in human B cells. Blood. 92:1998;2815-2822.
86. Ogata H., Su I., Miyake K., Nagai Y., Akashi S., Mecklenbräuer I., Rajewsky K., Kimoto M., Tarakhovsky A. The Toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J. Exp. Med. 195:2000;23-29.
87. Chan V.W.F., Mecklenbräuer I., Su I., Texido G., Leitges M., Carsetti R., Lowell C.A., Rajewsky K., Miyake K., Tarakhovsky A. The molecular mechanism of B cell activation by toll-like receptor protein RP-105. J. Exp. Med. 188:1998;93-101.
88. Bauer S., Kirschning C.J., Häcker H., Redecke V., Hausmann S., Akira S., Wagner H., Lipford G.B. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. U. S. A. 98:2001;9237-9242.
89. Slack J.L., Schooley K., Bonnert T.P., Mitcham J.L., Qwarnstrom E.E., Sims J.E., Dower S.K. Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways. J. Biol. Chem. 275:2000;4670-4678.
90. Radons J., Gabler S., Wesche H., Korherr C., Hofmeister R., Falk W. Identification of essential regions in the cytoplasmic tail of IL-1 receptor accessory protein critical for IL-1 signaling. J. Biol. Chem. 277:2002;16456-16463.
91. Xu Y., Tao X., Shen B., Horng T., Medzhitov R., Manley J.L., Tong L. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature. 408:2000;111-115.
92. Muzio M., Ni J., Feng P., Dixit V. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science. 278:1997;1612-1615.
93. Wesche H., Henzel W.J., Shillinglaw W., Li S., Cao Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity. 7:1997;837-847.
94. Burns K., Martinon F., Esslinger C., Pahl H., Schneider P., Bodmer J.-L., Di Marco F., French L., Tschopp J. MyD88, an adaptor protein involved in interleukin-1 signaling. J. Biol. Chem. 273:1998;12203-12209.
95. Martin M., Böl G., Eriksson A., Resch K., Brigelius-Flohé R. Interleukin-1 induced activation of a protein kinase co-precipitating with the type I IL-1 receptor in T cells. Eur. J. Immunol. 24:1994;1566-1571.
96. Cao Z., Henzel W.J., Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science. 271:1996;1128-1131.
97. Burns K., Cladworthy J., Martin L., Martinon F., Plumpton C., Maschera B., Lewis A., Ray K., Tschopp J., Volpe F. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat. Cell Biol. 2:2000;346-351.
98. Xiao T., Towb P., Wasserman S.A., Sprang S.R. Three-dimensional structure of a complex between the death domains of Pelle and Tube. Cell. 99:1999;545-555.
99. Cao Z., Xiong J., Takeuchi M., Kurama T., Goeddel D.V. TRAF6 is a signal transducer for interleukin-1. Nature. 383:1996;443-446.
100. Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z., Matsumoto K. The kinase TAK1 can activate the NIK-I kappa B as well as the MAP kinase cascade in the iL-1 signaling pathway. Nature. 398:1999;252-256.
101. Irie T., Muta T., Takeshige K. TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-kappaB in lipopolysaccharide-stimulated macrophages. FEBS Lett. 467:2000;160-164.
102. Takaesu G., Kishida S., Hiyama A., Yamaguchi K., Shibuya H., Irie K., Ninomiya-Tsuji J., Matsumoto K. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol. Cell. 5:2000;649-658.
103. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature. 410:2001;37-40.
104. Takaesu G., Ninomiya-Tsuji J., Kishida S., Li X., Stark G., Matsumoto M. Interleukin-1 (il-1) receptor-associated kinase leads to activation of tak1 by inducing tab2 translocation in the il-1 signaling pathway. Mol. Cell. Biol. 21:2001;2475-2484.
105. Deng L., Wang C., Spencer E., Yang L., Braun A., You J., Slaughter C., Pickart C., Chen Z.J. Activation of IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell. 103:2000;351-361.
106. Qian Y., Commane M., Ninomiya-Tsuji J., Matsumoto K., Li X. IRAK-mediated translocation of TRAF6 and TAB2 in the IL-1-induced activation of NFκB. J. Biol. Chem. 276:2001;41661-41667.
107. Kishimoto K., Matsumoto K., Ninomiya-Tsuji J. TAK1 mitogen-activated protein kinase kinase kinase is activated by auto-phosphorylation within its activation loop. J. Biol. Chem. 275:2000;7359-7364.
108. Wang C., Deng L., Hong M., Akkaraju G.R., Ji I., Chen Z.J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 412:2001;346-351.
109. Lomaga M.A., Yeh W.-C., Sarosi I., Duncan G.S., Furlonger C., Ho A., Morony S., Capparelli C., Van G., Kaufman S., van der Heiden A., Itie A., Wakeham A., Khoo W., Sasaki T., Cao Z., Penninger J.M., Paige C.J., Lacey D.L., Dunstan C.R., Boyle W.J., Goeddel D.V., Mak T.W. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40 and LPS signaling. Genes Dev. 13:1999;1015-1024.
110. Naito A., Azuma S., Tanaka S., Miyazaki T., Takai S., Takatsu K., Nako K., Nakamura K., Katsuki M., Yamamoto T., Inoue J. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells. 6:1999;353-362.
111. Baud V., Liu Z.-G., Bennett B., Suzuki N., Xia Y., Karin M. Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev. 13:1999;1297-1308.
112. Lee J., Mira-Arbibe L., Ulevitch R.J. TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide. J. Leukoc. Biol. 68:2000;909-915.
113. Kop E., Medzhitov R., Carothers J., Xiao C., Douglas I., Janeway C.A., Gosh S. ECSIT is an evolutionary conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes Dev. 13:1999;2059-2071.
114. Malinin N.L., Boldin M.P., Kovalenko A.V., Wallach D. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature. 385:1997;540-544.
115. Yin L., Wu L., Wesche H., Arthur C.D., White J.M., Goeddel D.V., Schreiber R.D. Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science. 291:2001;2162-2165.
116. Yamin T.-T., Miller D.K. The interleukin-1 receptor-associated kinase is degraded by proteosomes following its phosphorylation. J. Biol. Chem. 272:1997;21540-21547.
117. Jensen L.E., Whitehead A.S. IRAK1b, a novel alternative splice variant of interleukin-1 receptor associated kinase (IRAK), mediates interleukin-1 signaling and has prolonged stability. J. Biol. Chem. 276:2001;29037-29044.
118. Martin M.U., Kollewe C. Interleukin-1 receptor-associated kinase-1 (IRAK-1): a self-regulatory adapter molecule in the signaling cascade of the Toll/IL-1 receptor family. Signal Transduct. 1-2:2001;37-50 www.interscience.wiley.com.
119. Zhang G., Gosh S. Negative regulation of toll-like receptor-mediated signaling by Tollip. J. Biol. Chem. 277:2002;7059-7065.
120. Underhill D.M., Ozinsky A., Smith K.D., Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci. U. S. A. 96:1999;14459-14463.
121. Seki E., Tsutsui H., Nakano H., Tsuji N., Hoshino K., Adachi O., Adachi K., Futatsugi S., Kuida K., Takeuchi O., Okamura H., Fujimoto J., Akira S., Nakanishi K. Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta. J. Immunol. 166:2001;2651-2657.
122. Kasiho T., Takeuchi O., Kawai T., Hoshino K., Akira S. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J. Immunol. 166:2001;5688-5694.
123. Kasiho T., Akira S. Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice. Trends Immunol. 22:2001;78-83.
124. Kanakaraj P., Schafer P.H., Cavender D.E., Wu Y., Ngo K., Grealish P.F., Wadsworth S.A., Peterson P.A., Siekierka J.J., Harris C.A., Fung-Leung W.P. Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production. J. Exp. Med. 187:1998;2073-2079.
125. Thomas J.A., Allen J.L., Tsen M., Dubnicoff T., Danao J., Liao X.C., Cao Z., Wasserman S.A. Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. J. Immunol. 163:1999;978-984.
126. Kanakaraj P., Ngo K., Wu Y., Angulo A., Ghazal P., Harris C.A., Siekierka J.J., Peterson P.A., Fung-Leung W. Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice. J. Exp. Med. 189:1999;1129-1138.
127. Swantek J.L., Tsen M.F., Cobb M.H., Thomas J.A. IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. J. Immunol. 164:2000;4301-4306.
128. Wesche H., Gao X., Li X., Kirschning C.J., Stark G.R., Cao Z. IRAK-M is a novel member of the Pelle/Interleukin-1 receptor-associated kinase (IRAK) family. J. Biol. Chem. 274:1999;19403-19410.
129. Li X., Commane M., Burns C., Vithalani K., Cao Z., Stark G. Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for the IL-1 receptor-associated kinase. Mol. Cell. Biol. 19:1999;4643-4652.
130. Aliprantis A.O., Yang R.B., Weiss D.S., Godowski P., Zychlinsky A. The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J. 19:2000;3325-3336.
131. Aliprantis A.O., Yang R.B., Mark M.R., Suggett S., Devaux B., Radolf J.D., Klimpel G.R., Godowski P., Zychlinksi A. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science. 285:1999;736-739.
132. Onozaki K., Matsushima M., Aggarwal B.B., Oppenheim J.J. Human interleukin-1 is a cytocidal factor for several tumor cell lines. J. Immunol. 135:1985;3962-3968.
133. Re F., Strominger J.L. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem. 276:2001;37692-37699.
134. Holtmann H., Enninga J., Kälble S., Thiefes A., Dörrie A., Broemer M., Winzen R., Wilhelm A., Ninomiya-Tsuji J., Matsumoto K., Resch K., Kracht M. The MAPKKK TAK1 plays a central role in coupling the interleukin-1 receptor to both, transcriptional and RNA-targeted mechanisms in gene regulation. J. Biol. Chem. 276:2001;3508-3516.
135. Reddy S.A., Huang J.H., Liao W.S. Phosphatidylinositol 3-kinase in interleukin-signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation. J. Biol. Chem. 272:1997;29167-29173.
136. Sizemore N., Leung S., Stark G.R. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol. Cell. Biol. 19:1999;4798-4805.
137. Magde L.A., Pober J.S. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells. J. Biol. Chem. 275:2000;15458-15465.
138. Marmiroli S., Bavelloni A., Faenza I., Sirri A., Ognibene A., Cenni V., Tsukada J., Koyama Y., Ruzzene M., Ferri A., Auron P.E., Toker A., Maraldi N.M. Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I. FEBS Lett. 438:1998;49-54.
139. Bavelloni A., Santi S., Sirri A., Riccio M., Faenza I., Zini N., Cecchi S., Ferri A., Auron P., Marmiroli A.M., Marmiroli S. Phosphatidylinositol 3-kinase translocation to the nucleus is induced by interleukin 1 and prevented by mutation of interleukin 1 receptor in human osteosarcoma Saos-2 cells. J. Cell Sci. 112:1999;631-640.
140. Arbibe L., Mira J.-P., Teusch N., Kline L., Guha M., Mackman N., Godowski P.J., Ulevitch R.J., Knaus U.G. Toll-like receptor 2-mediated NF-κB activation requires a RAC-1 dependent pathway. Nat. Immun. 1:2000;533-540.
141. Jefferies C.A., O'Neill L.A. Rac1 regulates interleukin 1-induced nuclear factor kappaB activation in an inhibitory protein kappaBalpha-independent manner by enhancing the ability of the p65 subunit to transactivate gene expression. J. Biol. Chem. 275:2000;3114-3120.
142. Jefferies C., Bowie A., Brady G., Cooke E.-L., Li X., O'Neill L.A.J. Transactivation by the p65 subunit of NF-κB in response to interleukin-1 (IL-1) involves MyD88, IL-1 receptor-associated kinase 1, TRAF-6 and RAc1. Mol. Cell. Biol. 21:2001;4544-4552.
143. MacGillivray M.K., Cruz T.F., McCulloch C.A.G. The recruitment of the interleukin-1 receptor-associated kinase (IRAK) into focal adhesion complexes is required for IL-1β-induced ERK activation. J. Biol. Chem. 275:2000;23509-23515.
144. Schmitz M.L., Bacher S., Kracht M. IκB-independent control of NF-κB activity by modulatory phosphorylations. Trends Biochem. Sci. 26:2001;186-190.
145. Caunt C.J., Kiss-Toth E., Carlotti F., Chapman R., Qwarnstrom E.E. Ras controls tumor necrosis factor receptor-associated factor (TRAF)6-dependent induction of nuclear factor-kappa b. Selective regulation through receptor signaling components. J. Biol. Chem. 276:2001;6280-6288.
146. Vale T., Ngo T.T., White M.A., Lipsky P.E. Raf-induced transformation requires an interleukin 1 autocrine loop. Cancer Res. 61:2001;602-607.
147. Bagrodia S., Dérijard B., Davis R.J., Cerione R.A. Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation. J. Biol. Chem. 270:1995;7995-27998.
148. Puls A., Eliopoulos A.G., Nobes C.D., Bridges T., Young L.S., Hall A. Activation of the small GTPase Cdc42 by the inflammatory cytokine TNF(alpha) and IL-1, and the Epstein-Barr virus transforming protein LMP1. J. Cell Sci. 112:1999;2983-2992.
149. Palsson E.M., Popoff M., Thelestam M., O'Neill L.A.J. Divergent roles for Ras and Rap in the activation of p38 mitogen-activated protein kinase by interleukin-1. J. Biol. Chem. 275:2000;7818-7825.
150. Dreikhausen U., Varga G., Homann F., Barth H., Aktories K., Resch K., Szamel M. Regulation by rho family GTPases of IL-1 receptor induced signaling: C3-like chimeric toxin and Clostridium difficile toxin B inhibit signaling pathways involved in IL-2 gene expression. Eur. J. Immunol.
151. Davis W., Stephens L.R., Hawkins P.T., Saklatvala J. Synergistic activation of JNK/SAPK by interleukin-1 and platelet-derived growth factor is independent of Rac and Cdc42. Biochem. J. 338:1999;387-392.
152. Singh R., Wang B., Shirvaikar A., Khan S., Kamat S., Schelling J.R., Konieczkowski M., Sedor J.R. The IL-1 receptor and Rho directly associate to drive cell activation in inflammation. J. Clin. Invest. 103:1999;1561-1570.
153. Schütze S., Machleidt T., Krönke M. The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction. J. Leukoc. Biol. 56:1994;533-541.
154. Hofmeister R., Wiegmann K., Korherr C., Bernardo K., Krönke M., Falk W. Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein. J. Biol. Chem. 272:1997;27730-27736.
155. Andrieu N., Salvayre R., Levade T. Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts. Biochem. J. 303:1994;341-345.
156. Manthey C.L., Schuchmann E.H. Acid sphingomyelinase-derived ceramide is not required for inflammatory cytokine signalling in murine macrophages. Cytokine. 10:1998;654-661.
157. Adam-Klages S., Adam D., Wiegmann K., Struve S., Kolanus W., Schneider-Mergener J., Krönke M. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell. 86:1996;937-947.
158. Bourbon N.A., Yun J., Kester M. Ceramide directly activates protein kinase C ζ to regulate a stress-activated protein kinase signaling complex. J. Biol. Chem. 275:2000;35617-35623.
159. Schneider C., Delorme N., El Batouri H., Hornebeck W., Haye B., Martiny L. Interleukin-1 beta action in porcine thyroid cells involves the ceramide signalling pathway. Cytokine. 13:2001;174-178.
160. Sanz L., Diaz-Meco M.T., Nakano H., Moscat J. The atypical PKC-interacting protein p62 channels NF-κB activation by the IL-1-TRAF6 pathway. EMBO J. 19:2000;1576-1586.
161. Diaz-Meco M.T., Dominguez I., Sanz L., Dent P., Lozano J., Municio M.M., Berra E., Hay R.T., Sturgill T.W., Moscat J. ζPKC induces phosphorylation and inactivation of IκBα in vitro. EMBO J. 13:1994;2842-2848.
162. Diaz-Meco M.T., Lozano J., Municio M.M., Berra E., Frutto S., Sanz L., Moscat J. Evidence for the in vitro and in vivo interaction of Ras with protein kinase C ζ J. Biol. Chem. 269:1994;31706-31710.
163. Bonizzi G., Piette J., Schoonbroodt S., Merville M.P., Bours V. Role of the protein kinase C lambda/iota isoform in nuclear factor-kappaB activation by interleukin-1beta and tumor necrosis factor-alpha: cell type specificities. Biochem. Pharmacol. 57:1999;713-720.
164. 2s regulating NF-κB activation in response to TNF-α and IL-1β J. Biol. Chem. 276:2001;35344-35351.
165. Limatola C., Barbino B., Nista A., Santoni A. Interleukin 1-beta-induced protein kinase C-zeta activation is mimicked by exogenous phospholipase D. Biochem. J. 321:1997;497-501.
166. Garcia J.G., Stasek J.E., Bahler C., Natarajan V. Interleukin 1-stimulated prostacyclin synthesis in endothelium: lack of phospholipase C, phospholipase D, or protein kinase C involvement in early signal transduction. J. Lab. Clin. Med. 120:1992;929-940.
167. Bursten S.L., Harris W.E., Bomsztyk K., Lovett D. Interleukin-1 rapidly stimulates lysophophatide acyltransferase and phosphatide phosphohydrolase activities in human mesangial cells. J. Biol. Chem. 266:1991;20732-20743.
168. Bursten S., Harris W.E. Interleukin-1 stimulates phosphatidic acid-mediated phospholipase D activity in human mesangial cells. Am. J. Pathol. 266:1994;C1093-C1104.
169. Derevianko A., Graeber T., D'Amico R., Simms H.H. The role of neutrophil-derived oxidants as second messengers in interleukin 1beta-stimulated cells. Shock. 10:1998;54-61.
170. 2-terminal kinase is required for intercellular adhesion molecule-1 expression mediated by interleukin-1β: involvement of sequential activation of tyrosine kinase, nuclear factor-κB-inducing kinase, and IκB kinase 2. Mol. Pharmacol. 58:2000;1479-1489.
171. 2 biosynthesis by IL-1beta is mediated by PKC and mitogen-activated protein kinases in murine astrocytes. Br. J. Pharmacol. 131:2000;152-159.
172. Bird T.A., Schooley K., Dower S.K., Gaen H., Virca G.D. Activation of nuclear transcription factor NF-κB by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of its p65 subunit. J. Biol. Chem. 272:1997;32606-32612.
173. Guesdon F., Knight C.G., Rawlinson L.M., Saklatvala J. Dual specificity of the interleukin 1- and tumor necrosis factor-activated β casein kinase. J. Biol. Chem. 272:1997;30017-30024.
174. Li S., Strelow A., Fontana E.J., Wesche H. IRAK-4; a novel member of the iRAK family with the properties of an IRAK-kinase. Proc. Natl. Acad. Sci. U. S. A. 99:2002;5567-5572.
175. Suzuki N., Suzuki S., Duncan G.S., Millar D.G., Wada T., Mirtsos C., Takada H., Wakeham A., Itie A., Li S., Penninger J.M., Wesche H., Ohashi P.S., Mak T.W., Yeh W.-C. Severe impairment of interleukin-1 and Toll-like receptor signaling in mice lacking IRAK-4. Nature. 415:2002;750-756.